These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 21816291

  • 21. Differentiation between hypoxic and non-hypoxic experimental tumors by dynamic contrast-enhanced magnetic resonance imaging.
    Gulliksrud K, Øvrebø KM, Mathiesen B, Rofstad EK.
    Radiother Oncol; 2011 Mar; 98(3):360-4. PubMed ID: 21262548
    [Abstract] [Full Text] [Related]

  • 22. Assessment of fraction of radiobiologically hypoxic cells in human melanoma xenografts by dynamic contrast-enhanced MRI.
    Egeland TA, Gaustad JV, Vestvik IK, Benjaminsen IC, Mathiesen B, Rofstad EK.
    Magn Reson Med; 2006 Apr; 55(4):874-82. PubMed ID: 16506163
    [Abstract] [Full Text] [Related]

  • 23. The tumor bed effect: increased metastatic dissemination from hypoxia-induced up-regulation of metastasis-promoting gene products.
    Rofstad EK, Mathiesen B, Henriksen K, Kindem K, Galappathi K.
    Cancer Res; 2005 Mar 15; 65(6):2387-96. PubMed ID: 15781654
    [Abstract] [Full Text] [Related]

  • 24. Assessment of microvascular density, extracellular volume fraction, and radiobiological hypoxia in human melanoma xenografts by dynamic contrast-enhanced MRI.
    Vestvik IK, Egeland TA, Gaustad JV, Mathiesen B, Rofstad EK.
    J Magn Reson Imaging; 2007 Oct 15; 26(4):1033-42. PubMed ID: 17896373
    [Abstract] [Full Text] [Related]

  • 25. Assessment of hypoxia and radiation response in intramuscular experimental tumors by dynamic contrast-enhanced magnetic resonance imaging.
    Øvrebø KM, Hompland T, Mathiesen B, Rofstad EK.
    Radiother Oncol; 2012 Mar 15; 102(3):429-35. PubMed ID: 22197352
    [Abstract] [Full Text] [Related]

  • 26. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.
    Wilmes LJ, Pallavicini MG, Fleming LM, Gibbs J, Wang D, Li KL, Partridge SC, Henry RG, Shalinsky DR, Hu-Lowe D, Park JW, McShane TM, Lu Y, Brasch RC, Hylton NM.
    Magn Reson Imaging; 2007 Apr 15; 25(3):319-27. PubMed ID: 17371720
    [Abstract] [Full Text] [Related]

  • 27. Dynamic contrast-enhanced (DCE) derived transfer coefficient (ktrans) is a surrogate marker of matrix metalloproteinase 9 (MMP-9) expression in brain tuberculomas.
    Haris M, Husain N, Singh A, Awasthi R, Singh Rathore RK, Husain M, Gupta RK.
    J Magn Reson Imaging; 2008 Sep 15; 28(3):588-97. PubMed ID: 18777539
    [Abstract] [Full Text] [Related]

  • 28. [Gadolinium-loaded nanoparticle as a novel molecular imaging contrast agent for magnetic resonance imaging].
    Liu LZ, Guo GJ, Zeng MS, Lü YC, Liu XW, Cui CY, Wu PH, Li L.
    Zhonghua Yi Xue Za Zhi; 2007 Jan 23; 87(4):240-3. PubMed ID: 17425867
    [Abstract] [Full Text] [Related]

  • 29. Preclinical evaluation of Gd-DTPA and gadomelitol as contrast agents in DCE-MRI of cervical carcinoma interstitial fluid pressure.
    Hompland T, Ellingsen C, Rofstad EK.
    BMC Cancer; 2012 Nov 22; 12():544. PubMed ID: 23173554
    [Abstract] [Full Text] [Related]

  • 30. Overexpression of vascular endothelial growth factor 165 drives peritumor interstitial convection and induces lymphatic drain: magnetic resonance imaging, confocal microscopy, and histological tracking of triple-labeled albumin.
    Dafni H, Israely T, Bhujwalla ZM, Benjamin LE, Neeman M.
    Cancer Res; 2002 Nov 15; 62(22):6731-9. PubMed ID: 12438274
    [Abstract] [Full Text] [Related]

  • 31. Assessment of tumor blood perfusion by high-resolution dynamic contrast-enhanced MRI: a preclinical study of human melanoma xenografts.
    Benjaminsen IC, Graff BA, Brurberg KG, Rofstad EK.
    Magn Reson Med; 2004 Aug 15; 52(2):269-76. PubMed ID: 15282808
    [Abstract] [Full Text] [Related]

  • 32. Heterogeneity in the angiogenic response of a BT474 human breast cancer to a novel vascular endothelial growth factor-receptor tyrosine kinase inhibitor: assessment by voxel analysis of dynamic contrast-enhanced MRI.
    Li KL, Wilmes LJ, Henry RG, Pallavicini MG, Park JW, Hu-Lowe DD, McShane TM, Shalinsky DR, Fu YJ, Brasch RC, Hylton NM.
    J Magn Reson Imaging; 2005 Oct 15; 22(4):511-9. PubMed ID: 16161072
    [Abstract] [Full Text] [Related]

  • 33. Magnetic resonance imaging of tumor necrosis.
    Egeland TA, Gaustad JV, Galappathi K, Rofstad EK.
    Acta Oncol; 2011 Apr 15; 50(3):427-34. PubMed ID: 20950229
    [Abstract] [Full Text] [Related]

  • 34. Dynamic contrast-enhanced (DCE) MRI assessment of microvascular characteristics in the murine orthotopic pancreatic cancer model.
    Wu L, Lv P, Zhang H, Fu C, Yao X, Wang C, Zeng M, Li Y, Wang X.
    Magn Reson Imaging; 2015 Jul 15; 33(6):737-60. PubMed ID: 25169584
    [Abstract] [Full Text] [Related]

  • 35. Targeted magnetic resonance imaging with intraperitoneal and intravenous streptavidin (SA)-DTPA-Gd: a comparative study in tumor-bearing nude mice.
    Ye J, Xu YK, Liu X, Lü GS.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Feb 15; 26(2):139-43. PubMed ID: 16503514
    [Abstract] [Full Text] [Related]

  • 36. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
    Yuan Z, Liu SY, Xiao XS, Zhong GR, Jiang QJ.
    Zhonghua Yi Xue Za Zhi; 2007 Mar 13; 87(10):673-8. PubMed ID: 17553304
    [Abstract] [Full Text] [Related]

  • 37. Segmentation of dynamic contrast enhanced magnetic resonance imaging data.
    Nielsen T, Mouridsen K, Maxwell RJ, Stødkilde-Jørgensen H, Østergaard L, Horsman MR.
    Acta Oncol; 2008 Mar 13; 47(7):1265-70. PubMed ID: 18661437
    [Abstract] [Full Text] [Related]

  • 38. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
    Mendichovszky IA, Cutajar M, Gordon I.
    Eur J Radiol; 2009 Sep 13; 71(3):576-81. PubMed ID: 19004588
    [Abstract] [Full Text] [Related]

  • 39. Fluctuating and diffusion-limited hypoxia in hypoxia-induced metastasis.
    Rofstad EK, Galappathi K, Mathiesen B, Ruud EB.
    Clin Cancer Res; 2007 Apr 01; 13(7):1971-8. PubMed ID: 17360973
    [Abstract] [Full Text] [Related]

  • 40. Comparison of single- and dual-tracer pharmacokinetic modeling of dynamic contrast-enhanced MRI data using low, medium, and high molecular weight contrast agents.
    Orth RC, Bankson J, Price R, Jackson EF.
    Magn Reson Med; 2007 Oct 01; 58(4):705-16. PubMed ID: 17899608
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.